@MillerLabNeuro

Tim Miller lab | Washington University School of Medicine | Translational ALS and Alzheimer's disease research

 St Louis, MO
millerlab.wustl.edu
Joined April 2019
  • Tweets168
  • Following213
  • Followers704
26Media
Miller Lab retweeted
Wade Self@wade_self17 Sep 2024
I am honored to be a part of @NIHprevents' next #PreventionInFocus webinar on October 10 at 2:00 p.m. ET, to discuss the promise of strategies to prevent Alzheimer’s disease. Register at prevention.nih.gov/education…
3
1
11
1,558
BREAKING: the FDA has approved a new drug called toferson for a rare form of ALS caused by mutations in the gene SOD1. #WashUMed researcher @MillerLabNeuro, MD, PhD, led the international clinical trials. @ALSCenterWashU @biogen medicine.wustl.edu/news/drug…

Drug for rare form of ALS, based in part on WashU research, approved by FDA | WashU Medicine

Washington University neurologist led international trials of the drug, tofersen

medicine.washu.edu
1
14
1
22
6,790
New SOD1 #ALS drug candidate, #tofersen, is up for review by an FDA Advisory Committee on Wednesday, March 22nd from 9:15 am - 6 pm EST. You can watch the meeting virtually here: youtube.com/live/K0k6Jfcc5uM
3
1
5
876
Miller Lab retweeted
WashU@WashU14 Nov 2022
“They are exceptional change makers." Neuroscience majors Sam Norwitz and Ephraim Oyetunji of #WashU23 were finalists for the Rhodes Scholarship, one of the world’s most prestigious academic honors, to study at the University of Oxford in England. bit.ly/3trNygE
1
4
Miller Lab retweeted
Keith Mayl@DrMayl16 Nov 2022
Read our latest paper out in @NatureComms on genotype-phenotype correlations in SOD1-#ALS. This is the largest study of its kind for #SOD1 variants. Great work led by @opie_martin and @AlfredoIacoange at @KingsCollegeLon ! nature.com/articles/s41467-0…
1
6
32
Delighted to share a major step forward in treating #ALS. Published results for ASO therapy #Tofersen for #SOD1 ALS medicine.wustl.edu/news/inve… Tremendous thank you to the trial participants, their caregivers, and site personnel.
2
20
2
75
I've been writing research articles for over 10 years now and one of the hardest parts is writing consistently and efficiently without procrastinating. I'm going to share some of my tips here 🧵 1/10
77
1,338
249
11,320
Miller Lab retweeted
Ayala Lab@AyalaLab117 Nov 2021
We are thrilled to share our latest story. Congratulations to Zack and the whole team on the publication of our work: Specific RNA interactions promote TDP‐43 multivalent phase separation and maintain liquid properties | EMBO reports embopress.org/doi/full/10.15…
5
7
3
41
Congratulations to ENDURE scholar Ephraim Oyetunji on winning an award for his poster at ABRCMS! abrcms.org/index.php/program…
2
1
17
Game changer 🐭 academic.oup.com/brain/advan…
7
23
Thank you @NIHDirector for shedding light on #CallingCards (CC), a technology we're developing with Mitra Lab to produce, as you phrased, "a cumulative history and map" of transcriptional activity in mouse brain. Stay tuned for the CC updates we're brewing! #BRAINinitiative #NIH
This Post is from an account that no longer exists. Learn more
5
1
37
Miller Lab retweeted
Alzforum@alzforum29 Jul 2021
Two new tools for TREM2 research: antisense oligonucleotides and antibody single-chain variable fragments. #alzheimersdisease @WUSTL @UniofOxford ow.ly/cTVo50FGCrS
12
1
14
Miller Lab retweeted
WashU@WashU17 May 2021
Chelsey Carter of #WashU21 centers her research on the illness experience of Black and white Americans living with ALS in her hometown of St. Louis. Her experience has helped her to see how structural racism could impact care in different ways. bit.ly/3nVxv72
1
2
11
InPrint is hosting 3 workshops, on June 10, June 17, and June 24! We'd love for you to join us. RSVP quickly -- The first 50 to register (see link in text) will receive an Uber Eat voucher for attending!!
11
6
14
Our next InPrint Spotlight is here! Say hello to our very first Editor-In-Chief @KathleenSchoch, who developed InPrint and officially started the program in January 2018. Follow today’s thread to learn about Kathleen and her career path! /1 @WUSTL @WUSTLPostdoc @WUSTLGradCareer
3
6
1
21
Interesting study published in Nature Medicine suggesting perivascular fibroblasts play a critical role in ALS pathogenesis. rdcu.be/ciPj5 & rdcu.be/ciKQO
1
1
2
RECRUITING!!! We are looking for up to 2 talented #postdoc fellows/predoc/research scientists to join our efforts to untangle the mechanisms of TBI and its connections to Alzheimer’s disease. Please apply and RT! More info: bit.ly/3drMIIx. @WUSTLPostdoc, @WashuWups
14
1
22
Hi! We here @CarpeRibosomam are looking for postdocs! Please RT or forward to folks you think might be interested. neurojobs.sfn.org/job/29077/…
42
1
25
Miller Lab retweeted
TweetALS@TweetALSMND5 Jan 2021
#ICYMI Repeat length is an important driver of #C9orf72 #ALS #FTD suggests a study now published @hmg_journal Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice bit.ly/358mV4A @ranumlab #WangLab
1
11
14
Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease nature.com/articles/s41593-0…

Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory...

Nature Neuroscience - Alzheimer’s disease is often considered a disease of neurons. This study reveals that astrocytes are also impaired by the disease and that these cells contribute more to...

nature.com
12
4
57
Load more